Cargando…

Cyclophosphamide mechanism of action in preclinical tecemotide studies

Detalles Bibliográficos
Autores principales:	Hance, Ken, Tighe, Robert, Qi, Jin, Hastings, William, Qin, Guozhong, Marelli, Bo, Wang, Hong, Yu, Huakui, Zhang, Yanping, Xu, Xiaomei, Guzman, Wilson, Wong, Masie, Kradjian, Giorgio, Brunkhorst, Beatrice, Sabzevari, Helen, Lan, Yan, Hofmeister, Robert, Wolf, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990996/ http://dx.doi.org/10.1186/2051-1426-1-S1-P75

Ejemplares similares

Clarifying the pharmacodynamics of tecemotide (L-BLP25)-based combination therapy
por: Kao, Chiao-Jung, et al.
Publicado: (2013)

The immunocytokine NHS-IL12 as a potential cancer therapeutic
por: Fallon, Jonathan, et al.
Publicado: (2014)

NHS-IL12 and bintrafusp alfa combination therapy enhances antitumor activity in preclinical cancer models
por: Xu, Chunxiao, et al.
Publicado: (2021)

Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC)
por: Schimanski, Carl Christoph, et al.
Publicado: (2020)

Systemic immunotherapy of superficial mouse bladder cancer with Avelumab (MSB0010718C), an anti-PD-L1 immune checkpoint inhibitor
por: Vandeveer, Amanda, et al.
Publicado: (2015)

Big Learning Data
por: Masie, Elliott
Publicado: (2013)

DNA-PK Inhibitor Peposertib Amplifies Radiation-Induced Inflammatory Micronucleation and Enhances TGFβ/PD-L1 Targeted Cancer Immunotherapy
por: Carr, Michael I., et al.
Publicado: (2022)

High Dose Cyclophosphamide Treatment for Autoimmune Disorders
por: Brodsky, Robert A.
Publicado: (2002)

Cyclophosphamide causes osteoporosis in C57BL/6 male mice: suppressive effects of cyclophosphamide on osteoblastogenesis and osteoclastogenesis
por: Zhao, Dongfeng, et al.
Publicado: (2017)

Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis
por: Lee, Maxwell Y., et al.
Publicado: (2021)

Similarities and differences between helminth parasites and cancer cell lines in shaping human monocytes: Insights into parallel mechanisms of immune evasion
por: Narasimhan, Prakash Babu, et al.
Publicado: (2018)

Combined use of cyclophosphamide and Chalone 19-peptide in experimental breast cancer
por: Huang, Yuanxi, et al.
Publicado: (2013)

Lipidomics of cyclophosphamide 4‐hydroxylation in patients receiving post‐transplant cyclophosphamide
por: Navarro, Sandi L., et al.
Publicado: (2022)

A Review of Cyclophosphamide
por: Fox, B. W.
Publicado: (1975)

Treatment associated Mantle Cell Lymphoma with Cyclophosphamide therapy for Granulomatosis with Polyangiitis
por: Sheehy, Robert, et al.
Publicado: (2015)

Changes in nerve growth factor signaling in female mice with cyclophosphamide-induced cystitis
por: Hsiang, Harrison W., et al.
Publicado: (2023)

Fluorouracil Catabolism in the Combination Treatment of Cyclophosphamide, Methotrexate and Fluorouracil
por: De Bruijn, Ernst A., et al.
Publicado: (1992)

Is there any difference between busulfan-cyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?
por: Bahçecioğlu, Ömer Faruk, et al.
Publicado: (2021)

Mesothelin-targeting T cells bearing a novel T cell receptor fusion construct (TRuC) exhibit potent antitumor efficacy against solid tumors
por: Ding, Jian, et al.
Publicado: (2023)

Thermochemotherapy-induced resistance to cyclophosphamide.
por: Urano, M., et al.
Publicado: (1988)

Distribution and pharmacokinetics of cyclophosphamide in the rat.
por: Talha, M. R., et al.
Publicado: (1980)

Cytotoxicity of cyclophosphamide in the rat incisor.
por: Adatia, A. K.
Publicado: (1975)

Cyclophosphamide-Induced Lung Injury
por: Pugh, Dan, et al.
Publicado: (2018)

Role of metabolites of cyclophosphamide in cardiotoxicity
por: Kurauchi, Koichiro, et al.
Publicado: (2017)

Cyclophosphamide: Death: case report
Publicado: (2021)

Cyclophosphamide: Thrombocytopenia: case report
Publicado: (2021)

Cyclophosphamide treatment for hypertension and renal injury in an experimental model of systemic lupus erythematosus
por: Wolf, Victoria L., et al.
Publicado: (2019)

Imatinib Mesylate Reduces Voiding Frequency in Female Mice With Acute Cyclophosphamide-Induced Cystitis
por: Perkins, Megan E., et al.
Publicado: (2022)

Effects of collagen peptides from Micropterus salmoides skin on oxidative damage induced by cyclophosphamide in mice
por: Han, Mengyao, et al.
Publicado: (2022)

The Role of Beetroot Extract in Overcoming Chemoresistance of Neoadjuvant Adriamycin Cyclophosphamide Regimen by Targeting Immune Response in Tumor Microenvironment: A Preclinical Study in Mammary Adenocarcinoma Rats
por: Susilowati, Sri, et al.
Publicado: (2022)

Evidence for the active intermediate in cyclophosphamide metabolism.
por: Cox, P. J.
Publicado: (1973)

Cimetidine enhancement of cyclophosphamide antitumour activity.
por: Dorr, R. T., et al.
Publicado: (1982)

The effect of cyclophosphamide on MSV-H oncogenesis.
por: Branca, M., et al.
Publicado: (1977)

The effect of cyclophosphamide on Fas-mediated apoptosis.
por: Lee, J. H., et al.
Publicado: (1997)

Cyclophosphamide in alveolar hemorrahge due to leptospirosis
por: Joshi, Anand V., et al.
Publicado: (2010)

Topotecan and Cyclophosphamide in Adults with Relapsed Sarcoma
por: Blanchette, P., et al.
Publicado: (2012)

Prevention of the exposure by cyclophosphamide oral tablet
por: Hanada, Takae, et al.
Publicado: (2015)

Mycophenolate versus Cyclophosphamide for Lupus Nephritis
por: Sahay, M., et al.
Publicado: (2018)

T‐cell modulation by cyclophosphamide for tumour therapy
por: Hughes, Ellyn, et al.
Publicado: (2018)

Weight loss effects of methotrexate and cyclophosphamide
por: Bridges, Dave
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ouqskb7p4e73k4lch5hl6r8tgh